SCHEMBL40748

SCHEMBL40748

[CH2]C=Cc1ccc(O)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 6/20 0.59
KDM4E B2RXH2 3/20 0.54
ALDH1A1 P00352 3/20 0.54
MAPT P10636 3/20 0.54
CYP2C9 P11712 3/20 0.54
CA12 O43570 3/20 0.54
CA1 P00915 3/20 0.54
CA2 P00918 3/20 0.54
CA3 P07451 3/20 0.54
CA4 P22748 3/20 0.54
CA6 P23280 3/20 0.54
CA5A P35218 3/20 0.54
CA7 P43166 3/20 0.54
CA9 Q16790 3/20 0.54
CA14 Q9ULX7 3/20 0.54
CA5B Q9Y2D0 3/20 0.54
MAOB P27338 3/20 0.54
TYR P14679 3/20 0.54
AKR1B1 P15121 3/20 0.54
CA13 Q8N1Q1 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL434806 1.00 APP (0.59) APPKDM4EALDH1A1MAPTCYP2C9
SCHEMBL9678787 0.82 APP (0.74) APPKDM4EALDH1A1MAPTCYP2C9
SCHEMBL6266987 0.82 APP (0.74) APPKDM4EALDH1A1MAPTCYP2C9
SCHEMBL9678794 0.82 APP (0.74) APPKDM4EALDH1A1MAPTCYP2C9
Trans-4,4'-Dihydroxystilbene SCHEMBL13339135 0.82 APP (0.74) APPKDM4EALDH1A1MAPTCYP2C9
SCHEMBL6266989 0.82 APP (0.74) APPKDM4EALDH1A1MAPTCYP2C9
SCHEMBL6266983 0.82 APP (0.74) APPKDM4EALDH1A1MAPTCYP2C9
Trans-4,4'-Dihydroxystilbene SCHEMBL145659 0.82 APP (0.74) APPKDM4EALDH1A1MAPTCYP2C9
Trans-4,4'-Dihydroxystilbene SCHEMBL491346 0.82 APP (0.74) APPKDM4EALDH1A1MAPTCYP2C9
SCHEMBL11439096 0.77 APP (0.94) APPKDM4EALDH1A1MAPTCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230119068-A1 METHODS FOR RAPID SYNTHESIS OF PYRANOANTHOCYANINS OHIO STATE INNOVATION FOUNDATION 2023-04-20 US claimed
WO-2023275142-A1 FRAGRANCED COSMETIC COMPOSITION COMPRISING AT LEAST ONE ORGANIC ACID ESTER, AN ANTHOCYANI(DI)N DYE AND A FRAGRANCING MATERIAL L'OREAL (FR) 2023-01-05 WO claimed
WO-2022144369-A1 FRAGRANCED COSMETIC COMPOSITION COMPRISING AN ORGANIC ACID, A NATURAL ANTHOCYANI(DI)N DYE AND A FRAGRANCING MATERIAL, AND PROCESS FOR TREATING KERATIN MATERIALS AND/OR CLOTHING USING THE COMPOSITION L'OREAL (FR) 2022-07-07 WO claimed
WO-2021163679-A1 METHODS FOR RAPID SYNTHESIS OF PYRANOANTHOCYANINS OHIO STATE INNOVATION FOUNDATION (US) 2021-08-19 WO claimed
US-6054321-A FORMING THREE-DIMENSIONAL STRUCTURE OF A FLUORESCENT PROTEIN, CONSTRUCTING MODEL OF OTHER FLUORESCENT PROTEIN USING FIRST AS TEMPLATE, MAKING MUTANTS BY REPLACING AMINO ACID(S) WITHIN 5 ANGSTROMS OF ANY ATOM OF CHROMOPHORE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-04-25 US claimed
EP-0710289-A1 PROCESS FOR PRODUCING 4-HYDROXY-CINNAMYL ALCOHOLS QUEST INT (NL) 1996-05-08 EP claimed
WO-1995002062-A1 PROCESS FOR PRODUCING 4-HYDROXY-CINNAMYL ALCOHOLS QUEST INTERNATIONAL B.V. (NL) 1995-01-19 WO claimed
US-11987754-B2 Solvolysis process for combined feedstock UPM-KYMMENE CORPORATION (FI) 2024-05-21 US disclosed
US-11987759-B2 Solvolysis process UPM-KYMMENE CORPORATION (FI) 2024-05-21 US disclosed
CN-117568387-A Method for improving peanut anthocyanin content by utilizing gene editing 山东省农业科学院 2024-02-20 CN disclosed
US-20240052530-A1 Lignin Fractionation and Fabrication for Quality Carbon Fiber THE TEXAS A&M UNIVERSITY SYSTEM (US) 2024-02-15 US disclosed
US-11873498-B2 Tissue specific reduction of lignin THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-01-16 US disclosed
US-11840776-B2 Lignin fractionation and fabrication for quality carbon fiber THE TEXAS A&M UNIVERSITY SYSTEM (US) 2023-12-12 US disclosed
EP-0670831-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-09-13 EP disclosed
WO-1995009159-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1995-04-06 WO disclosed
WO-1995002062-A1 PROCESS FOR PRODUCING 4-HYDROXY-CINNAMYL ALCOHOLS QUEST INTERNATIONAL B.V. (NL) 1995-01-19 WO disclosed
WO-1995002062-A1 PROCESS FOR PRODUCING 4-HYDROXY-CINNAMYL ALCOHOLS QUEST INTERNATIONAL B.V. (NL) 1995-01-19 WO disclosed
WO-1994029474-A1 TREATMENT OF LIGNOCELLULOSE TO MINIMIZE BINDING OF CELLULASE MIDWEST RESEARCH INSTITUTE (US) 1994-12-22 WO disclosed
EP-0277626-A2 Synthetic GHRH analogs The Administrators of The Tulane Educational Fund (US) 1988-08-10 EP disclosed
US-4684740-A Production of 2,6-bis (4-hydroxy-3,5-dimethoxyphenyl-3,7-dioxabicyclo (3.3.0) octane JUJO PAPER CO., LTD. (JP) 1987-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230119068-A1 METHODS FOR RAPID SYNTHESIS OF PYRANOANTHOCYANINS HCCS, PPOX, RNGTT APP 3271/4885KDM4E 2442/4885ALDH1A1 2302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.